758 related articles for article (PubMed ID: 18328841)
1. Aspirin desensitization in patients undergoing percutaneous coronary interventions with stent implantation.
Rossini R; Angiolillo DJ; Musumeci G; Scuri P; Invernizzi P; Bass TA; Mihalcsik L; Gavazzi A
Am J Cardiol; 2008 Mar; 101(6):786-9. PubMed ID: 18328841
[TBL] [Abstract][Full Text] [Related]
2. Aspirin desensitization in patients undergoing planned or urgent coronary stent implantation. A single-center experience.
De Luca G; Verdoia M; Binda G; Schaffer A; Suryapranata H; Marino P
Int J Cardiol; 2013 Jul; 167(2):561-3. PubMed ID: 22365313
[TBL] [Abstract][Full Text] [Related]
3. Rapid desensitization procedure for patients with aspirin hypersensitivity undergoing coronary stenting.
Silberman S; Neukirch-Stoop C; Steg PG
Am J Cardiol; 2005 Feb; 95(4):509-10. PubMed ID: 15695141
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of heparin-coated stent in early setting of acute myocardial infarction.
Shin EK; Son JW; Sohn MS; Jin DK; Park GS; Koh KK; Ahn TH; Choi IS
Catheter Cardiovasc Interv; 2001 Mar; 52(3):306-12. PubMed ID: 11246241
[TBL] [Abstract][Full Text] [Related]
5. [Aspirin in patients undergoing percutaneous coronary intervention].
Güleç S
Anadolu Kardiyol Derg; 2007 Dec; 7 Suppl 2():9-13. PubMed ID: 18160361
[TBL] [Abstract][Full Text] [Related]
6. Clopidogrel desensitization after drug-eluting stent placement.
von Tiehl KF; Price MJ; Valencia R; Ludington KJ; Teirstein PS; Simon RA
J Am Coll Cardiol; 2007 Nov; 50(21):2039-43. PubMed ID: 18021870
[TBL] [Abstract][Full Text] [Related]
7. [Acetylsalicylic acid hypersensitivity in a patient with coronary artery disease and insulin-dependent diabetes mellitus].
Podolecka E; Ciszewski A; Kepka C; Mazurkiewicz Ł; Ruzyłło W
Kardiol Pol; 2008 Jan; 66(1):70-2. PubMed ID: 18266189
[TBL] [Abstract][Full Text] [Related]
8. Aspirin Desensitization in Patients With Coronary Artery Disease: Results of the Multicenter ADAPTED Registry (Aspirin Desensitization in Patients With Coronary Artery Disease).
Rossini R; Iorio A; Pozzi R; Bianco M; Musumeci G; Leonardi S; Lettieri C; Bossi I; Colombo P; Rigattieri S; Dossena C; Anzuini A; Capodanno D; Senni M; Angiolillo DJ
Circ Cardiovasc Interv; 2017 Feb; 10(2):. PubMed ID: 28193678
[TBL] [Abstract][Full Text] [Related]
9. Obesity and cardiovascular thrombotic events in patients undergoing percutaneous coronary intervention with drug-eluting stents.
Wang ZJ; Zhou YJ; Liu YY; Yu M; Shi DM; Zhao YX; Guo YH; Cheng WJ; Nie B; Ge HL; Jia DA; Yang SW; Yan ZX
Heart; 2009 Oct; 95(19):1587-92. PubMed ID: 19592387
[TBL] [Abstract][Full Text] [Related]
10. Drug-eluting coronary stents: many meta-analyses, little benefit.
Prescrire Int; 2009 Apr; 18(100):70-4. PubMed ID: 19585727
[TBL] [Abstract][Full Text] [Related]
11. Timing of thrombotic events in patients receiving 2 weeks of clopidogrel therapy post bare metal coronary artery stenting: a New Zealand retrospective study.
Tie S; Wong CK; Yap J; Wilkins G; Williams M; Kay P
N Z Med J; 2007 Jun; 120(1255):U2553. PubMed ID: 17546101
[TBL] [Abstract][Full Text] [Related]
12. Percutaneous coronary intervention: assessing coronary vascular risk associated with bare-metal and drug-eluting stents.
Spinler SA
Am J Manag Care; 2009 Mar; 15(2 Suppl):S42-7. PubMed ID: 19355808
[TBL] [Abstract][Full Text] [Related]
13. Long-term clinical outcomes of real-world experience using sirolimus-eluting stents in saphenous vein graft disease.
Ramana RK; Ronan A; Cohoon K; Homan D; Sutherland J; Steen L; Liu J; Loeb H; Lewis BE
Catheter Cardiovasc Interv; 2008 Jun; 71(7):886-93. PubMed ID: 18412238
[TBL] [Abstract][Full Text] [Related]
14. Impact of clopidogrel resistance on thrombotic events after percutaneous coronary intervention with drug-eluting stent.
Wang ZJ; Zhou YJ; Liu YY; Yu M; Shi DM; Zhao YX; Guo YH; Cheng WJ; Jia de A; Cao Z; Nie B; Ge HL; Yang SW; Yan ZX
Thromb Res; 2009 May; 124(1):46-51. PubMed ID: 19041120
[TBL] [Abstract][Full Text] [Related]
15. Aspirin desensitisation for Chinese patients with coronary artery disease.
Lee JK; Tsui KL; Cheung CY; Chau CH; Chan HL; Wu KL; Cheung GS; Choi MC; Chan KK; Li SK
Hong Kong Med J; 2013 Jun; 19(3):207-13. PubMed ID: 23650199
[TBL] [Abstract][Full Text] [Related]
16. Temporal relation between Clopidogrel cessation and stent thrombosis after drug-eluting stent implantation.
Roy P; Bonello L; Torguson R; Okabe T; Pinto Slottow TL; Steinberg DH; Kaneshige K; Xue Z; Satler LF; Kent KM; Suddath WO; Pichard AD; Lindsay J; Waksman R
Am J Cardiol; 2009 Mar; 103(6):801-5. PubMed ID: 19268735
[TBL] [Abstract][Full Text] [Related]
17. Percutaneous coronary intervention utilizing a new endothelial progenitor cells antibody-coated stent: a prospective single-center registry in high-risk patients.
Miglionico M; Patti G; D'Ambrosio A; Di Sciascio G
Catheter Cardiovasc Interv; 2008 Apr; 71(5):600-4. PubMed ID: 18360849
[TBL] [Abstract][Full Text] [Related]
18. Clopidogrel desensitization: case report and review of published protocols.
Owen P; Garner J; Hergott L; Page RL
Pharmacotherapy; 2008 Feb; 28(2):259-70. PubMed ID: 18225971
[TBL] [Abstract][Full Text] [Related]
19. Long-term outcome of patients of over 85 years old with acute coronary syndrome undergoing percutaneous coronary stenting: a comparison of bare metal stent and drug eluting stent.
Ma HY; Zhou YJ; Dick RJ; Shi DM; Liu YY; Cheng WJ; Guo YH; Wang JL; Ge HL
Chin Med J (Engl); 2008 May; 121(10):887-91. PubMed ID: 18706201
[TBL] [Abstract][Full Text] [Related]
20. Successful clopidogrel desensitization after drug-eluting stent implantation.
Kammer RT
J Invasive Cardiol; 2009 Mar; 21(3):134-5. PubMed ID: 19258645
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
